Koch, M., & Wiese, M. (2013). Gene expression signatures of angiocidin and darapladib treatment connect to therapy options in cervical cancer. Journal of cancer research and clinical oncology, 139(2), 259-267. https://doi.org/10.1007/s00432-012-1317-9
Chicago Style (17th ed.) CitationKoch, Martin, and Michael Wiese. "Gene Expression Signatures of Angiocidin and Darapladib Treatment Connect to Therapy Options in Cervical Cancer." Journal of Cancer Research and Clinical Oncology 139, no. 2 (2013): 259-267. https://doi.org/10.1007/s00432-012-1317-9.
MLA (9th ed.) CitationKoch, Martin, and Michael Wiese. "Gene Expression Signatures of Angiocidin and Darapladib Treatment Connect to Therapy Options in Cervical Cancer." Journal of Cancer Research and Clinical Oncology, vol. 139, no. 2, 2013, pp. 259-267, https://doi.org/10.1007/s00432-012-1317-9.